Nura (USA) Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $210K

Nura (USA) General Information

Description

Developer of therapeutics for behavioral disorders and neurodegenerative diseases. The company develops therapeutics for behavioral and neurodegenerative diseases with particular emphasis on G Protein-coupled receptor (GPCR) and phosphodiesterase (PDE) targets expressed in the brain. Its programs include schizophrenia, pain, and attention-deficit hyperactivity disorder.

Contact Information

Website
www.nurainc.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1124 Columbia Street
  • Seattle, WA 98104
  • United States
+1 (206)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 1124 Columbia Street
  • Seattle, WA 98104
  • United States
+1 (206)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nura (USA) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 07-Sep-2006 $210K Completed Product Development
2. Grant 01-Jan-2004 Completed Product Development
1. Early Stage VC (Series A) 22-Sep-2004 $9.5M $9.5M Completed Product Development
To view Nura (USA)’s complete valuation and funding history, request access »

Nura (USA) Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
ARCH Venture Partners Venture Capital Minority
Aravis Growth/Expansion Minority
Cercano Management PE/Buyout Minority
Linkagene Venture Capital Minority
National Institute of Mental Health Government
You’re viewing 5 of 6 investors. Get the full list »

Nura (USA) FAQs

  • When was Nura (USA) founded?

    Nura (USA) was founded in 2003.

  • Where is Nura (USA) headquartered?

    Nura (USA) is headquartered in Seattle, WA.

  • What industry is Nura (USA) in?

    Nura (USA)’s primary industry is Drug Discovery.

  • Is Nura (USA) a private or public company?

    Nura (USA) is a Private company.

  • What is the current valuation of Nura (USA)?

    The current valuation of Nura (USA) is .

  • What is Nura (USA)’s current revenue?

    The current revenue for Nura (USA) is .

  • How much funding has Nura (USA) raised over time?

    Nura (USA) has raised $9.5M.

  • Who are Nura (USA)’s investors?

    ARCH Venture Partners, Aravis, Cercano Management, Linkagene, and National Institute of Mental Health are 5 of 6 investors who have invested in Nura (USA).

  • When was Nura (USA) acquired?

    Nura (USA) was acquired on 07-Sep-2006.

  • Who acquired Nura (USA)?

    Nura (USA) was acquired by Omeros.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process